Menu

Tim Kim focuses his practice on the representation of both underwriters and issuers on a variety of capital markets transactions. Tim also regularly counsels publicly traded companies on general corporate matters, including SEC reporting and corporate governance.

Download full bio 

Experience

  • Apellis Pharmaceuticals – $402.5 Million Follow-On Offering 

Education

  • Duke University School of Law
    JD, 2016

  • University of Miami
    BA, Philosophy
    2011


Admissions & Credentials

New York

North Carolina